Cystoisosporiasis of the Colon (ICD-11: 1A33.1) - Complete Coding and Diagnostic Guide

1. Introduction

Cystoisosporiasis of the colon, coded as 1A33.1 in the International Classification of Diseases in its 11th revision (ICD-11), represents a specific parasitic infection of the large intestine caused by the protozoan Cystoisospora belli (formerly known as Isospora belli). This condition constitutes a localized manifestation of an intestinal infection that may affect different segments of the gastrointestinal tract, being particularly relevant in populations with immunocompromise.

The clinical importance of this condition transcends its epidemiological prevalence, as it represents one of the most significant opportunistic infections in patients with immunodeficiency, especially those living with HIV/AIDS in advanced stages. Although considered relatively rare in immunocompetent populations, cystoisosporiasis of the colon can cause debilitating chronic diarrhea, severe intestinal malabsorption, and significant weight loss when not treated appropriately.

From a public health perspective, the recognition and accurate coding of this condition are fundamental for appropriate epidemiological monitoring, proper allocation of diagnostic and therapeutic resources, and implementation of preventive strategies in vulnerable populations. Transmission occurs primarily through the fecal-oral route, making sanitary and hygiene conditions determining factors in its geographic distribution.

Correct coding using code 1A33.1 is critical for multiple reasons: it allows precise differentiation between infections of the small intestine and colon, facilitates comparative epidemiological studies, aids in planning specific treatments, and ensures appropriate reimbursement by health systems. Furthermore, appropriate documentation of this condition contributes to understanding the natural history of the disease and to the development of evidence-based clinical protocols.

2. Correct ICD-11 Code

Code: 1A33.1

Description: Cystoisosporiasis of the colon

Parent category: 1A33 - Cystoisosporiasis

Official definition: Cystoisosporiasis of the colon is an inflammation of the large intestine caused by the protozoan Isospora belli (currently reclassified as Cystoisospora belli).

This specific code was created in ICD-11 to allow precise anatomical localization of cystoisospora infection, differentiating it from other presentations of the same parasitosis. The hierarchical classification places this code as a subcategory of general cystoisosporiasis (1A33), recognizing that the pathogen can affect different segments of the gastrointestinal tract with distinct clinical manifestations.

The anatomical specificity of this code reflects the modern understanding that the localization of infection in the colon may present particular clinical, diagnostic, and prognostic characteristics, differentiating itself from small intestine infection. This distinction is particularly relevant for therapeutic planning and for the evaluation of potential complications.

Code 1A33.1 should be used when there is diagnostic confirmation that Cystoisospora belli infection is predominantly localized in the large intestine, whether through endoscopic, histopathological, or radiological evidence demonstrating specific colon involvement. Adequate documentation of anatomical localization is essential for the correct application of this code.

3. When to Use This Code

The code 1A33.1 should be applied in specific clinical scenarios where there is clear evidence of Cystoisospora belli infection of the colon. Below, we present detailed practical situations:

Scenario 1: Immunocompromised patient with chronic diarrhea and colonoscopic confirmation

A patient with advanced immunosuppression presents with persistent watery diarrhea for more than four weeks, associated with abdominal pain predominantly in the descending colon and sigmoid region. Colonoscopy reveals edematous and hyperemic colonic mucosa, with areas of superficial erosion. Colon biopsies demonstrate Cystoisospora belli oocysts on histopathological analysis, confirming specific involvement of the large intestine. This is the classic scenario for use of code 1A33.1.

Scenario 2: Differential diagnosis after exclusion of small intestine infection

A patient with chronic gastrointestinal symptoms undergoes complete investigation. Upper endoscopy with duodenal biopsies reveals no presence of the parasite, but stool examinations demonstrate Cystoisospora belli oocysts. Imaging studies suggest predominant thickening of the colonic wall. Rectosigmoidoscopy with biopsy confirms the presence of the protozoan specifically in the colon, justifying the use of code 1A33.1 instead of 1A33.0.

Scenario 3: Presentation with specific colonic symptoms

A patient presents with tenesmus, urgency of defecation, frequent evacuations with small volume and presence of mucus in stool, symptoms typical of colonic involvement. Parasitological stool examinations identify Cystoisospora belli oocysts. Abdominal computed tomography demonstrates segmental thickening of the colon without significant involvement of the small intestine. The clinical-radiological correlation justifies coding as 1A33.1.

Scenario 4: Complication in transplant patient

A patient who underwent solid organ transplantation, on potent immunosuppressive therapy, develops infectious colitis. After exclusion of bacterial, viral, and fungal causes, colonic biopsy reveals Cystoisospora belli infection. The specific location in the colon and parasitological confirmation make code 1A33.1 appropriate.

Scenario 5: Recurrence of infection with colonic manifestation

A patient previously treated for cystoisosporiasis presents with symptom recurrence, now with predominance of manifestations related to the colon: pain in the left lower quadrant, altered bowel habit with pasty and frequent stools, and occasional rectal bleeding. Colonoscopy confirms parasitic colitis caused by Cystoisospora belli, justifying the use of code 1A33.1 for this specific presentation.

Scenario 6: Diagnosis in the context of persistent diarrhea investigation

A patient with unexplained chronic diarrhea undergoes complete investigation protocol. Multiple stool samples are analyzed, revealing Cystoisospora belli oocysts. Endoscopic studies demonstrate that the inflammatory process is restricted to the colon, without evidence of small intestine involvement. Clear documentation of anatomical location allows precise coding as 1A33.1.

4. When NOT to Use This Code

It is fundamental to recognize situations where code 1A33.1 should not be applied, avoiding coding errors that may compromise medical records and epidemiological data:

Predominant small intestine infection: When clinical, endoscopic, or histopathological findings demonstrate that Cystoisospora belli infection is located primarily in the duodenum, jejunum, or ileum, the appropriate code is 1A33.0 (Cystoisosporiasis of the small intestine), not 1A33.1. Differentiation is crucial, as clinical manifestations and complications may differ significantly.

Cystoisosporiasis without anatomical specification: In situations where there is confirmation of Cystoisospora belli infection, but there is insufficient data to determine whether involvement is of the small intestine or colon, the generic code 1A33 (Cystoisosporiasis) should be used instead of incorrectly specifying the location.

Other causes of colitis: Conditions such as ulcerative colitis, Crohn's disease with colonic involvement, pseudomembranous colitis caused by Clostridioides difficile, ischemic colitis, or cytomegalovirus colitis require their own specific codes. Even if there are similar colonic symptoms, the absence of parasitological confirmation of Cystoisospora belli excludes the use of code 1A33.1.

Other intestinal parasitoses: Infections by other protozoa such as Cryptosporidium, Cyclospora cayetanensis, Giardia lamblia, or Entamoeba histolytica have specific codes in ICD-11 and should not be coded as 1A33.1, even if they present similar symptomatology.

Diarrhea of undefined etiology: When a patient presents with gastrointestinal symptoms compatible with colitis, but there is no laboratory or histopathological confirmation of the presence of Cystoisospora belli, the diagnosis should not be presumed and code 1A33.1 should not be applied. Parasitological confirmation is essential for appropriate coding.

Asymptomatic colonization: In rare situations where oocysts of Cystoisospora belli are identified in stool samples from asymptomatic individuals (generally in screening contexts), without evidence of colonic inflammation or clinical symptoms, the application of code 1A33.1 may not be appropriate, and the clinical relevance of the finding should be considered.

5. Coding Step by Step

Step 1: Assess diagnostic criteria

The first fundamental step for correct coding is to confirm the diagnosis of cystoisosporiasis of the colon through appropriate methods. Diagnostic confirmation requires the identification of the parasite Cystoisospora belli through one or more of the following methods:

Parasitological stool examination: Multiple samples (ideally three or more) should be collected and analyzed using concentration techniques. The oocysts of Cystoisospora belli are characteristic, measuring approximately 20-30 micrometers in length, with an ellipsoid shape and double wall. Staining with special techniques (such as modified Ziehl-Neelsen staining) increases diagnostic sensitivity.

Intestinal biopsy: Colonoscopy with biopsy is considered the most definitive method, allowing direct visualization of the parasite in colonic tissues and assessment of the degree of associated inflammation. Histopathology may reveal oocysts within enterocytes or in the lamina propria, in addition to characteristic inflammatory changes.

Clinical evaluation: The presence of chronic diarrhea (persistent for more than two to four weeks), weight loss, abdominal pain, low-grade fever, and specific symptoms of colonic involvement (tenesmus, urgency to defecate, presence of mucus or blood in stool) should be documented. The context of immunosuppression significantly increases diagnostic probability.

Step 2: Verify specifiers

After confirming the diagnosis, it is necessary to assess specific characteristics that justify the use of code 1A33.1:

Anatomical location: Document evidence that the infectious process is predominantly located in the colon. This may include endoscopic findings showing colonic inflammation, imaging studies demonstrating thickening of the large intestine wall, or clinical symptoms typical of colonic involvement.

Severity: Although code 1A33.1 does not have specific severity subclassifications in ICD-11, it is important to document the intensity of symptoms, the degree of nutritional compromise, the presence of complications, and the impact on the patient's quality of life.

Duration: Characterize whether it is acute, subacute, or chronic infection. Cystoisosporiasis frequently presents as chronic disease in immunocompromised patients, with symptoms persisting for weeks or months.

Immunological context: Document the patient's immunological status, including CD4+ cell count in patients with HIV, use of immunosuppressants, presence of other conditions that compromise immunity.

Step 3: Differentiate from other codes

The most critical differentiation is with code 1A33.0 (Cystoisosporiasis of the small intestine):

1A33.0 vs. 1A33.1: The fundamental distinction is based on the predominant anatomical location of the infection. Code 1A33.0 should be used when there is evidence that the small intestine (duodenum, jejunum, or ileum) is the primary site of infection, usually manifesting with profuse watery diarrhea, significant malabsorption, and steatorrhea. Code 1A33.1 is appropriate when the colon is the predominant site, with symptoms more characteristic of colitis.

Differentiation criteria: Use endoscopic findings (upper gastrointestinal endoscopy versus colonoscopy), location of positive biopsies, pattern of clinical symptoms (malabsorption versus colonic symptoms), and radiological findings (small intestine involvement versus colon) to determine the appropriate code.

Mixed infection: In rare cases where there is clear evidence of simultaneous and significant involvement of both the small intestine and colon, it may be necessary to use both codes or consider the generic code 1A33 if differentiation is not possible.

Step 4: Required documentation

To adequately justify the use of code 1A33.1, the medical documentation must include:

Checklist of mandatory information:

• Detailed description of gastrointestinal symptoms, including duration and characteristics
• Result of parasitological stool examinations with specific identification of Cystoisospora belli
• Colonoscopy report, if performed, describing macroscopic findings
• Anatomopathological report of colonic biopsies, when available
• Patient's immunological status, including CD4+ count if applicable
• Exclusion of other causes of colitis through appropriate examinations
• Response to specific treatment for cystoisosporiasis
• Clear justification for the colonic location of the infection

Adequate documentation: The documentation should explicitly state that the diagnosis is cystoisosporiasis with specific colonic involvement, differentiating it from other presentations of the disease. Terms such as "colitis due to Cystoisospora belli" or "colonic cystoisosporiasis" help clarify appropriate coding.

6. Complete Practical Example

Clinical Case

A 38-year-old patient with a diagnosis of HIV for six years, under irregular follow-up and inconsistent use of antiretroviral therapy, presents to the emergency department with the chief complaint of persistent diarrhea for eight weeks. He reports liquid to pasty stools, six to eight times per day, associated with abdominal cramping predominantly in the lower abdomen region, fecal urgency, and occasional presence of mucus in the stool. He denies high fever but reports occasional afternoon low-grade fever. He lost approximately eight kilograms of weight during this period.

On physical examination, he appears emaciated and dehydrated, with stable vital signs except for mild tachycardia. The abdomen is tender on deep palpation in the left iliac fossa and descending colon region, without signs of peritoneal irritation. The proctologic examination is normal.

Laboratory tests reveal CD4+ count of 85 cells/mm³, elevated HIV viral load, mild normocytic anemia, and hypoalbuminemia. Initial stool samples were negative for pathogenic bacteria, Clostridioides difficile toxins, and common parasites. Due to persistence of symptoms, three additional stool samples were requested with concentration techniques and special staining, which identified oocysts of Cystoisospora belli.

Colonoscopy was performed, which demonstrated diffusely edematous and hyperemic colonic mucosa, with areas of superficial erosion, more pronounced in the descending colon and sigmoid. The visualized terminal ileum appeared normal. Biopsies were obtained from the ascending, transverse, descending, and sigmoid colon.

Histopathologic examination of the colonic biopsies revealed chronic inflammatory process of the mucosa with presence of oocysts of Cystoisospora belli within enterocytes and in the lamina propria, confirming the diagnosis of cystoisosporiasis of the colon. The biopsies showed no evidence of other opportunistic infections or neoplasms.

Step-by-Step Coding

Criteria analysis:

1. Parasitologic confirmation: Presence of oocysts of Cystoisospora belli identified in multiple stool samples and confirmed on colonic biopsies.

2. Anatomic location: Clear evidence of colon involvement through colonoscopic findings (diffuse colonic mucosal inflammation) and histopathologic findings (parasites identified specifically in colonic tissue). The visualized terminal ileum was normal, without evidence of small intestine involvement.

3. Clinical manifestations: Symptoms compatible with colitis (fecal urgency, implicit tenesmus, pain in the descending colon region, presence of mucus) rather than typical symptoms of small intestine malabsorption.

4. Clinical context: Immunocompromised patient with advanced HIV (CD4+ < 100 cells/mm³), known risk group for cystoisosporiasis.

Code selected: 1A33.1

Complete justification:

The code 1A33.1 (Cystoisosporiasis of the colon) is the appropriate code for this case because:

• There is definitive confirmation of infection by Cystoisospora belli through parasitologic and histopathologic methods
• The predominant anatomic location of the infection is the colon, as demonstrated by endoscopic findings and biopsies
• The clinical symptoms are consistent with colonic involvement
• There is no evidence of significant small intestine involvement, excluding the use of code 1A33.0
• The documentation is complete and unequivocally supports the diagnosis and specific location

Applicable complementary codes:

• Code for HIV with low CD4+ count (underlying condition that predisposes to opportunistic infection)
• Code for protein-calorie malnutrition, if appropriate (consequence of the disease)
• Code for dehydration, if clinically significant at the time of evaluation

This case illustrates the importance of complete investigation and detailed documentation to allow precise and specific coding of cystoisosporiasis of the colon.

7. Related Codes and Differentiation

Within the Same Category

1A33.0: Cystoisosporiasis of the small intestine

This is the main differentiation within category 1A33. Code 1A33.0 should be used when there is evidence that Cystoisospora belli infection is predominantly located in the small intestine (duodenum, jejunum, or ileum).

When to use 1A33.0 vs. 1A33.1:

The fundamental difference is based on the predominant anatomical location of the infection. Use 1A33.0 when:

• Duodenal or jejunal biopsies demonstrate the presence of the parasite
• Symptoms are predominantly malabsorptive: profuse watery diarrhea, steatorrhea, significant nutritional deficiencies
• Upper gastrointestinal endoscopy reveals inflammatory changes in the duodenum
• Imaging studies show predominant involvement of the small intestine

Use 1A33.1 when:

• Colonoscopy with biopsies demonstrates colon infection
• Symptoms are typical of colitis: fecal urgency, tenesmus, pain in the colon region
• Imaging studies show colon wall thickening
• Upper gastrointestinal endoscopy is normal or shows minimal involvement

Main difference: Anatomical location is the definitive criterion. In cases where both segments are involved, the predominant site should be considered based on the extent of endoscopic findings, the intensity of symptoms related to each segment, and histopathological findings.

Differential Diagnoses

Cryptosporidiosis (specific code in ICD-11): Another common opportunistic infection in immunocompromised patients. Differentiated by identification of Cryptosporidium oocysts (smaller than those of Cystoisospora) in stool samples or biopsies. Modified acid-fast staining aids in differentiation.

Cyclosporiasis: Caused by Cyclospora cayetanensis, presents similar symptoms but oocysts are different on microscopic examination (larger and with characteristic autofluorescence under ultraviolet light).

Intestinal microsporidiosis: Caused by microsporidia, requires special staining techniques for identification. Spores are much smaller than Cystoisospora oocysts.

Cytomegalovirus colitis: Common in immunocompromised patients, differentiated by identification of characteristic viral inclusions in biopsies and specific PCR testing.

Inflammatory bowel disease: Ulcerative colitis or Crohn's disease may present with similar symptoms, but the absence of parasites in biopsies and the characteristic histopathological pattern allow for differentiation.

8. Differences with ICD-10

In ICD-10, cystoisosporiasis was coded more generically as A07.3 (Isosporiasis), without specific distinction between small intestine and colon involvement. This lack of anatomical specificity represented a limitation for detailed epidemiological studies and for understanding the different clinical presentations of the disease.

Main changes in ICD-11:

1. Anatomical specificity: ICD-11 introduced distinct codes for cystoisosporiasis of the small intestine (1A33.0) and colon (1A33.1), allowing more precise classification based on the location of infection.

2. Nomenclatural update: The code reflects the taxonomic reclassification of the parasite from Isospora belli to Cystoisospora belli, although both names are still recognized clinically.

3. Clearer hierarchy: The hierarchical structure of ICD-11 (1A33 as parent category, with 1A33.0 and 1A33.1 as subcategories) facilitates navigation and understanding of the relationships between different disease presentations.

4. Greater granularity: The ability to specify anatomical location allows better epidemiological tracking, comparisons between different populations, and evaluation of clinical presentation patterns.

Practical impact of these changes:

For healthcare professionals, the transition from ICD-10 to ICD-11 requires greater attention to documentation of the anatomical location of infection. While previously it was sufficient to confirm the diagnosis of cystoisosporiasis, it is now necessary to specify whether involvement is predominantly of the small intestine or colon, often requiring more detailed endoscopic investigation.

For health systems and researchers, greater specificity allows more refined analyses of the distribution and clinical characteristics of the disease, potentially leading to better management and prevention strategies.

9. Frequently Asked Questions

1. How is the definitive diagnosis of cystoisosporiasis of the colon made?

Definitive diagnosis requires identification of oocysts of Cystoisospora belli through parasitological examination of stool (ideally multiple samples with concentration techniques and special staining) or, preferably, through colonic biopsy obtained during colonoscopy. Histopathology allows not only confirmation of parasite presence but also assessment of the degree of inflammation and exclusion of other conditions. Colonoscopy is particularly useful for confirming that involvement is predominantly colonic, justifying the use of code 1A33.1.

2. Is treatment available in public health systems?

The first-line treatment for cystoisosporiasis is sulfamethoxazole-trimethoprim, an antibiotic widely available and relatively inexpensive, generally accessible through public health systems in various countries. For patients with allergy or intolerance to sulfonamides, alternatives such as ciprofloxacin or pyrimethamine may be used. In immunocompromised patients, especially those with HIV, immune reconstitution through effective antiretroviral therapy is fundamental for definitive cure and prevention of recurrence.

3. How long does treatment last?

Treatment duration varies according to the patient's immune status. In immunocompetent individuals, treatment generally lasts seven to ten days. In immunocompromised patients, especially those with HIV and low CD4+ counts, initial treatment may extend for three to four weeks, followed by maintenance therapy (secondary prophylaxis) until adequate immune recovery occurs. Clinical response generally occurs within one to two weeks of treatment initiation, with progressive improvement in diarrhea and associated symptoms.

4. Can this code be used in medical certificates and official documents?

Yes, code 1A33.1 can and should be used in medical certificates, clinical reports, and official documents when appropriate. Precise coding is important for adequate medical documentation, justification for work leave when necessary, and for health insurance and related benefits purposes. However, it is important to consider confidentiality issues, especially in patients with HIV, and to discuss with the patient the appropriate level of detail for each type of document.

5. Do patients with cystoisosporiasis of the colon need isolation?

Although cystoisosporiasis is transmitted via the fecal-oral route, strict hospital isolation is generally not necessary for most patients. However, contact precautions and rigorous hand hygiene are recommended, especially in hospital settings and for caregivers. Patients should be counseled about appropriate personal hygiene practices and hand washing to prevent transmission to others. In community settings, education about sanitation and hygiene is fundamental to prevent dissemination.

6. Can cystoisosporiasis of the colon cause serious complications?

In immunocompromised patients, untreated cystoisosporiasis of the colon can lead to significant complications, including severe malnutrition, severe dehydration, electrolyte imbalances, and rarely, intestinal perforation. Persistent chronic diarrhea can result in marked weight loss and deterioration of general condition. In rare cases, there may be extraintestinal dissemination of the parasite. Early and appropriate treatment, combined with improvement in immune status in patients with HIV, generally prevents these complications.

7. Is recurrence possible after treatment?

Yes, recurrence is relatively common in immunocompromised patients, especially those with HIV and persistently low CD4+ counts. The recurrence rate can be significant if adequate immune reconstitution does not occur. For this reason, many specialists recommend secondary prophylaxis (continuous suppressive treatment) in patients with severe immunosuppression until CD4+ count rises sustainably. Adherence to antiretroviral therapy in patients with HIV is fundamental to prevent recurrence.

8. How to differentiate cystoisosporiasis of the colon from other causes of chronic diarrhea in immunocompromised patients?

Differentiation requires a comprehensive diagnostic approach. Stool examinations should include screening for multiple pathogens (bacteria, parasites, viruses). Endoscopic examinations with biopsies are often necessary to identify the specific causative agent and assess the extent of intestinal involvement. The presence of characteristic oocysts of Cystoisospora belli in stool examinations or biopsies, especially when associated with endoscopic findings of colitis and compatible symptoms, establishes the diagnosis. It is important to remember that coinfections may occur, and identification of one pathogen does not necessarily exclude the presence of others.

---

Conclusion

Appropriate coding of cystoisosporiasis of the colon using ICD-11 code 1A33.1 requires clear understanding of diagnostic criteria, appropriate documentation of the anatomical location of infection, and careful differentiation from other disease presentations. The specificity introduced by ICD-11 allows better epidemiological and clinical characterization of this condition, contributing to improved care for affected patients. Diagnostic confirmation through parasitological methods and, when possible, endoscopic methods is fundamental to ensure coding accuracy and appropriate clinical management.

External References

This article was prepared based on reliable scientific sources:

1. 🌍 WHO ICD-11 - Cystoisosporiasis of the colon
2. 🔬 PubMed Research on Cystoisosporiasis of the colon
3. 🌍 WHO Health Topics
4. 📋 CDC - Centers for Disease Control
5. 📊 Clinical Evidence: Cystoisosporiasis of the colon
6. 📋 Ministry of Health - Brazil
7. 📊 Cochrane Systematic Reviews

References verified on 2026-02-04